A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the pharmacokinetic
(the exposure of the trial drug in the body) and pharmacodynamic (the effect of the
investigated drug on the body) properties of FIAsp (faster-acting insulin aspart) in subjects
with type 1 diabetes.